Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway
暂无分享,去创建一个
L. Rassenti | T. Kipps | P. Sabbatini | M. Kashyap | J. Castro | L. Cohen | P. Cardarelli | Deepak Kumar | H. Jones | M. Kuhné | Michael Y Choi | J. Melo-Cardenas | Amine Ale-Ali | S. Shelat | C. Amaya-Chanaga | M. Choi | A. Ale-Ali